Genmab — Maj 2015
-
Sagde han lige at: "we have included more data in the filing" ?
-
som om de var i gang med at skrive den
-
han sviner Elutuzumab
-
Dara langt bedre
-
off label anvendes alligevelk
-
Glæder at se ham i studiet på Børsen TV i morgen.
-
Hvad tid?
-
http://news.bms.com/press-release/partnering-news/elotuzumab-progression-free-survival-data-phase-2-study-patients-previ Fase 2 resultater med Elotuzumab og Lenalidomide
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind